Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus
AssigneeUniversidad Autonoma Metropolitana
InventorClaudia Angelica Soto Peredo
Life of this patent
Estimating the term…
Abstract
The present invention refers to a new compound containing Silymarin with Carbopol for the treatment of Diabetes Mellitus. This compound morphologically and structurally regenerates the damage that occurs in the pancreatic tissue in Diabetes Mellitus, and regenerates the insulin-producing pancreatic cells (β cells). It therefore regulates the serum levels of this hormone. Furthermore, it restores and maintains the normal concentrations of the blood glucose.
Claims5
A method of recovering endocrine pancreatic function in a patient in need thereof, which comprises
- orally administering to the patient an effective amount of a composition comprising silymarin and carbopol,
- wherein said composition induces the regeneration of damaged pancreatic cells.
A method of recovering endocrine pancreatic function in a patient in need thereof, which comprises orally administering to the patient an effective amount of a composition comprising silymarin and carbopol for 4 to 7 weeks, thereby regenerating damaged pancreatic cells.
Dependencies are inferred from the claim text.